Basal implants, how they work and what the evidence says

In this approach, basal refers to cortical bone walls, the hard layers used for support. The tooth-bearing part of a jaw may have lost volume while other walls remain potential anchor sites. This is not treatment without bone. The doctor must determine which bone is available and whether it can support the proposed reconstruction.

The implants discussed here are one-piece cortico-basal implants. The body entering the bone, the neck and the head supporting the replacement teeth are one titanium component. That head is also called an abutment. In many conventional systems, the implant body and the abutment are separate parts.

One-piece does not mean there is no thread. A thread anchors the implant in bone. If an advertisement describes a system as “screwless,” ask which connection it means. The exact manufacturer and model proposed for your treatment are to be confirmed with the clinic. Keep that identification separate from the name of the prosthetic material.

The implants can point toward different cortical walls. Their heads support a shared prosthesis, meaning the manufactured replacement teeth. The International Implant Foundation consensus describes joining the implants early through the prosthesis and distributing the forces produced by the bite.

The corticobasal approach aims to avoid bone grafts. Your doctor confirms whether it applies to your case at the evaluation with your test results. A CT scan provides three-dimensional images for assessing possible anchors. That description is not a determination that every patient qualifies. Suitability belongs to the treating doctor’s assessment.

All-on-4 is a different plan using four conventional implants for an arch, or row of teeth. The one-piece cortico-basal technique is not called All-on-4. Counting implants alone is not a useful comparison. Ask how each proposal obtains support, connects the teeth and handles maintenance.

Lazarov’s 2019 cohort followed 87 patients with 1,169 implants, with follow-up extending to 57 months. A cohort is a group followed after treatment. The paper reported overall survival of 95.7 percent. The scientific background for this guide also identifies inconsistent subgroup figures within the article.

Pałka and Lazarov reported another single-center series of 87 patients and 1,019 implants in 2019. Reported survival was 97 percent at 35 months. These findings describe those groups over those periods. They are not results from the clinics coordinated by Hexa Smile and cannot predict an individual patient’s outcome.

Survival means an implant remains in place. A surviving implant can still be part of a treatment requiring adjustments or prosthetic repairs. Because one patient may have many implants, an implant-level percentage does not tell you how many people needed additional care. Ask for both kinds of information when reviewing a clinic’s record.

Large series share authors connected with the IHDE system. Lazarov’s paper acknowledges support from the system’s foundation while declaring no funding. The International Implant Foundation consensus represents the approach of people developing and teaching the technique. It should be identified as such.

These connections do not erase the observations. They limit how confidently those observations can be generalized to other teams and settings. Independent groups, comparable patients and longer follow-up would help answer whether the same results can be reproduced elsewhere.

Patient satisfaction is another separate outcome. A favorable questionnaire does not measure implant loss many years later. A clinic should be able to identify which paper supports a claim and whether that paper measured survival, comfort, satisfaction or repair needs.

Habash and colleagues reviewed 17 publications in 2024. Eleven were case reports. Those reports describe individual experiences or small groups rather than a strong comparison between treatments. The review found that advantages over conventional implants remained uncertain and noted difficulty replacing failed basal implants.

The review also reported more pain and longer surgical time in one comparative trial. That finding should be discussed rather than replaced by a broad comfort promise. It does not establish how a particular patient will feel or what anesthesia plan a clinic will use. Those details are to be confirmed with the surgeon.

Panday and colleagues’ 2026 meta-analysis, as described in the scientific background, included five trials, 140 patients and 1,388 implants. A meta-analysis combines findings across studies. It rated certainty for survival as low and could not provide a direct comparison with current conventional implants.

Joshi and colleagues’ 2026 narrative review found insufficient evidence to recommend basal implants over conventional implants. The background review does not establish high-quality long-term outcomes. Promising clinical results exist, but the duration of those results and comparative benefit remain open questions.

The system’s consensus describes overload-related osteolysis, meaning bone loss associated with excessive forces. Mobility may develop. Management can include bite adjustment, additional implants or removal. The consensus places many overload problems within the first two years, making continuing access to care relevant to travel planning.

Bending the implant neck is described as part of placement in clinical series and recorded as a complication in reviews. The background research did not find adequate long-term data on fatigue fracture of the implant. Fatigue means the effect of repeated forces on a material. Ask the clinician what this uncertainty means for the specific model being proposed.

Reported prosthetic problems include loss of cement retention and framework fractures. Claims that peri-implantitis disappears are not supported. Peri-implantitis involves inflammation and bone loss around an implant. Some reports recorded no cases without stating diagnostic criteria, which limits the meaning of that observation.

If the proposal includes graphene, it is in the acrylic prosthesis. The implant itself is titanium. De Angelis and colleagues found no superiority over conventional milled acrylic in static strength testing. A laboratory material result cannot establish years of clinical performance for the complete reconstruction.

Ask how the prosthesis can be removed and who could maintain it in the United States. A one-piece implant does not allow the abutment to be replaced separately. The clinic’s follow-up schedule, repair terms and arrangements for local care are to be confirmed. A plan for those questions belongs beside the surgical proposal.

• Which cortical walls on my CT scan would provide support?
• What conventional or zygomatic alternatives have you considered?
• Which independent studies support this proposal?
• How many of your patients have you followed, and for how long?
• How do you identify and manage overload-related bone loss?
• How would you remove a failed implant or access the prosthesis?
• Which reviews require returning, and who can provide care in the United States?